WallStSmart

Bioceres Crop Solutions Corp (BIOX)vsCF Industries Holdings Inc (CF)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

CF Industries Holdings Inc generates 2127% more annual revenue ($7.08B vs $318.16M). CF leads profitability with a 20.5% profit margin vs -17.7%. BIOX appears more attractively valued with a PEG of 1.95. CF earns a higher WallStSmart Score of 76/100 (B+).

BIOX

Hold

50

out of 100

Grade: D+

Growth: 7.3Profit: 3.0Value: 6.7Quality: 5.0

CF

Strong Buy

76

out of 100

Grade: B+

Growth: 6.7Profit: 8.5Value: 7.3Quality: 8.3
Piotroski: 6/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BIOX.

CFUndervalued (+76.9%)

Margin of Safety

+76.9%

Fair Value

$419.80

Current Price

$128.11

$291.69 discount

UndervaluedFair: $419.80Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BIOX2 strengths · Avg: 9.0/10
Price/BookValuation
0.1x10/10

Reasonable price relative to book value

EPS GrowthGrowth
34.4%8/10

Earnings expanding 34.4% YoY

CF6 strengths · Avg: 8.7/10
Operating MarginProfitability
35.3%10/10

Strong operational efficiency at 35.3%

Return on EquityProfitability
23.4%9/10

Every $100 of equity generates 23 in profit

Profit MarginProfitability
20.5%9/10

Keeps 21 of every $100 in revenue as profit

P/E RatioValuation
14.3x8/10

Attractively priced relative to earnings

Revenue GrowthGrowth
22.8%8/10

Revenue surging 22.8% year-over-year

EPS GrowthGrowth
37.1%8/10

Earnings expanding 37.1% YoY

Areas to Watch

BIOX4 concerns · Avg: 2.8/10
PEG RatioValuation
1.954/10

Expensive relative to growth rate

Market CapQuality
$23.61M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-19.0%2/10

ROE of -19.0% — below average capital efficiency

Revenue GrowthGrowth
-16.4%2/10

Revenue declined 16.4%

CF1 concerns · Avg: 2.0/10
PEG RatioValuation
5.782/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : BIOX

The strongest argument for BIOX centers on Price/Book, EPS Growth.

Bull Case : CF

The strongest argument for CF centers on Operating Margin, Return on Equity, Profit Margin. Profitability is solid with margins at 20.5% and operating margin at 35.3%. Revenue growth of 22.8% demonstrates continued momentum.

Bear Case : BIOX

The primary concerns for BIOX are PEG Ratio, Market Cap, Return on Equity.

Bear Case : CF

The primary concerns for CF are PEG Ratio.

Key Dynamics to Monitor

BIOX profiles as a turnaround stock while CF is a growth play — different risk/reward profiles.

CF carries more volatility with a beta of 0.69 — expect wider price swings.

CF is growing revenue faster at 22.8% — sustainability is the question.

CF generates stronger free cash flow (313M), providing more financial flexibility.

Bottom Line

CF scores higher overall (76/100 vs 50/100), backed by strong 20.5% margins and 22.8% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Bioceres Crop Solutions Corp

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Bioceres Crop Solutions Corp.

CF Industries Holdings Inc

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

CF Industries Holdings, Inc. is a North American manufacturer and distributor of agricultural fertilizers, based in Deerfield, Illinois.

Visit Website →

Want to dig deeper into these stocks?